Progressive regression of left ventricular hypertrophy two years after bariatric surgery

Mohamed F Algahim1, Thomas R Lux, Joshua G Leichman

  • 1Department of Internal Medicine, Division of Cardiology, University of Texas Medical School at Houston, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Insights

Bariatric surgery significantly reduces left ventricular mass in obese women, even after weight loss plateaus. This sustained benefit suggests improved cardiovascular health and long-term survival due to neurohumoral regulation.

Area of Science:

  • Cardiology
  • Metabolic Medicine
  • Bariatric Surgery

Background:

  • Obesity is linked to increased left ventricular mass and cardiovascular disease.
  • Bariatric surgery improves hormonal and hemodynamic issues but long-term effects on body composition and left ventricular mass are unclear.

Purpose of the Study:

  • To investigate the long-term effects of bariatric surgery on body composition and left ventricular mass.

Main Methods:

  • 15 severely obese women with hypertension underwent bariatric surgery.
  • Measurements included left ventricular mass, body mass index (BMI), body composition (fat and lean mass), and metabolic markers at baseline and up to 24 months.

Main Results:

  • Left ventricular mass decreased linearly throughout the 24-month study.
  • Weight loss, fat mass loss, lean mass loss, and resting energy expenditure plateaued at 9 months.
  • Metabolic parameters normalized by 9 months and remained stable.

Conclusions:

  • Bariatric surgery sustains benefits on systemic metabolism and left ventricular mass, independent of weight loss plateaus.
  • Progressive reduction in left ventricular mass may be neurohumorally regulated, potentially improving long-term survival.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...